Patent application number | Description | Published |
20130066544 | Security and Tracking System - A security and tracking apparatus includes at least a first signaling unit and a second signaling unit, wherein the apparatus is adapted for transmitting the location of each signaling unit when the first and second signaling units are separated by more than a preselected distance. A method to locate a person, animal, or object, includes providing in contact with or at least in close proximity to the person, the animal, or the object, at least a first signaling unit and a second signaling unit, wherein each respective signaling unit is adapted for identifying the location of the signaling units and for transmitting the location of the signaling units when the first and second signaling units are separated more than a preselected distance; and activating the signaling units to transmit the location of the signaling units. | 03-14-2013 |
20140272175 | DUAL CURABLE COMPOSITION - A dual curable composition is provided, comprising a compound represented by formula (I): | 09-18-2014 |
20150077247 | Security and Tracking System - A security and tracking apparatus includes at least a first signaling unit and a second signaling unit, wherein the apparatus is adapted for transmitting the location of each signaling unit when the first and second signaling units are separated by more than a preselected distance. A method to locate a person, animal, or object, includes providing in contact with or at least in close proximity to the person, the animal, or the object, at least a first signaling unit and a second signaling unit, wherein each respective signaling unit is adapted for identifying the location of the signaling units and for transmitting the location of the signaling units when the first and second signaling units are separated more than a preselected distance; and activating the signaling units to transmit the location of the signaling units. | 03-19-2015 |
20150086797 | CORROSION-RESISTANT, CHROMIUM-FREE, SELF-PRIMING COATINGS CURABLE BY ULTRAVIOLET LIGHT - Corrosion-resistant, self-priming coatings that are curable by ultraviolet energy and methods for coating surfaces using such coatings have been provided. In an exemplary embodiment, a method for coating a surface includes formulating a chromium-free, self-priming coating, applying the chromium-free, self-priming coating to the surface, and curing the chromium-free, self-priming coating with ultraviolet light. | 03-26-2015 |
20160005304 | Security and Tracking System - A security and tracking apparatus includes at least a first signaling unit and a second signaling unit, wherein the apparatus is adapted for transmitting the location of each signaling unit when the first and second signaling units are separated by more than a preselected distance. A method to locate a person, animal, or object, includes providing in contact with or at least in close proximity to the person, the animal, or the object, at least a first signaling unit and a second signaling unit, wherein each respective signaling unit is adapted for identifying the location of the signaling units and for transmitting the location of the signaling units when the first and second signaling units are separated more than a preselected distance; and activating the signaling units to transmit the location of the signaling units. | 01-07-2016 |
Patent application number | Description | Published |
20120274385 | Transmission Gate - A transmission gate includes first and second transmission path terminals, a series connection of first and second field effect transistors (FETs), and a control circuit. The channels of the first and second FETs are coupled in series between the first transmission path terminal and the second transmission path terminal, such that a channel contact of the first FET is coupled to the second transmission path terminal and a channel contact of the second FET is coupled to the first transmission path terminal. The control circuit is configured to provide a control voltage for a gate contact of the first FET and a control voltage for a gate contact of the second FET, such that the control voltage for the gate contact of the first FET is, in a switch-off state of the transmission gate, based on a voltage present at the first transmission path terminal, and such that the control voltage for the gate contact of the second FET is, in the switch-off state of the transmission gate, based on a voltage present at the second transmission path terminal. | 11-01-2012 |
20140266116 | DIGITALLY CONTROLLED CURRENT MODE POWER CONVERTER - A current mode converter includes a converter stage comprising a first switch, a second switch, an inductor, and a capacitor, and a digital-to-analog converter configured to convert a digital target current signal to an analog current signal. The current mode converter further includes a slope compensation circuit coupled to the digital-to-analog converter and is configured to convert the analog target current signal to a slope compensated analog target signal. A comparator is coupled to the converter stage and the slope compensation stage and is configured to generate and output a signal when a value of an actual analog signal is equal to a value of the slope compensated analog target signal. | 09-18-2014 |
Patent application number | Description | Published |
20080199527 | Enteric Coated Azithromycin Multiparticulates - A pharmaceutical composition is disclosed which comprises multiparticulates wherein said multiparticulates further comprise an azithromycin core and an enteric coating disposed upon said azithromycin core. | 08-21-2008 |
20090011024 | Pharmaceutical compositions of dispersions of amorphous drugs mixed with polymers - A pharmaceutical composition comprises a dispersion comprising a low-solubility drug and a matrix combined with a concentration-enhancing polymer. At least a major portion of the drug is amorphous in the dispersion. The compositions improve the stability of the drug in the dispersion, and/or the concentration of drug in a use environment. | 01-08-2009 |
20110182947 | HYDROGEL-DRIVEN DRUG DOSAGE FORM - A controlled release dosage form has a coated core with the core comprising a drug-containing composition and a water-swellable composition, each occupying separate regions within the core. The drug-containing composition comprises a low-solubility drug and a drug-entraining agent. The coating around the core is water-permeable, water-insoluble and has at least one delivery port therethrough. A variety of formulations having specific drug release profiles are disclosed. | 07-28-2011 |
20110294902 | PHARMACEUTICAL COMPOSITIONS PROVIDING ENHANCED DRUG CONCENTRATIONS - A drug in a solubility-improved form is combined with a concentration-enhancing polymer in a sufficient amount so that the combination provides substantially enhanced drug concentration in a use environment relative to a control comprising the same amount of the same solubility-improved form of drug without the concentration-enhancing polymer. | 12-01-2011 |
20120259022 | PHARMACEUTICAL COMPOSITIONS PROVIDING ENHANCED DRUG CONCENTRATIONS - A drug in a solubility-improved form is combined with a concentration-enhancing polymer in a sufficient amount so that the combination provides substantially enhanced drug concentration in a use environment relative to a control comprising the same amount of the same solubility-improved form of drug without the concentration-enhancing polymer. | 10-11-2012 |
20120277315 | PHARMACEUTICAL COMPOSITIONS OF CHOLESTERYL ESTER TRANSFER PROTEIN INHIBITORS - A pharmaceutical composition comprises a solid amorphous dispersion of a cholesteryl ester transfer protein inhibitor and a concentration-enhancing polymer. | 11-01-2012 |
20120288542 | SOLID PHARMACEUTICAL DISPERSIONS WITH ENHANCED BIOAVAILABILITY - Spray dried solid dispersions comprising a sparingly soluble drug and hydroxypropylmethylcellulose acetate succinate (HPMCAS) provide increased aqueous solubility and/or biavailability in a use environment. | 11-15-2012 |
20120292797 | SOLID PHARMACEUTICAL DISPERSIONS WITH ENHANCED BIOAVAILABILITY - Spray dried solid dispersions comprising a sparingly soluble drug and hydroxypropylmethylcellulose acetate succinate (HPMCAS) provide increased aqueous solubility and/or biavailability in a use environment. | 11-22-2012 |
20120295988 | Pharmaceutical Compositions of Dispersions of Amorphous Drugs Mixed with Polymers - A pharmaceutical composition comprises a dispersion comprising a low-solubility drug and a matrix combined with a concentration-enhancing polymer. At least a major portion of the drug is amorphous in the dispersion. The compositions improve the stability of the drug in the dispersion, and/or the concentration of drug in a use environment. | 11-22-2012 |
20120328679 | SOLID PHARMACEUTICAL DISPERSIONS WITH ENHANCED BIOAVAILABILITY - Spray dried solid dispersions comprising a sparingly soluble drug and hydroxypropylmethylcellulose acetate succinate (HPMCAS) provide increased aqueous solubility and/or bioavailability in a use environment. | 12-27-2012 |
20130224301 | SOLID PHARMACEUTICAL DISPERSIONS WITH ENHANCED BIOAVAILABILITY - Spray dried solid dispersions comprising a sparingly soluble drug and hydroxypropylmethylcellulose acetate succinate (HPMCAS) provide increased aqueous solubility and/or bioavailability in a use environment. | 08-29-2013 |
20130345236 | PHARMACEUTICAL COMPOSITIONS PROVIDING ENHANCED DRUG CONCENTRATIONS - A drug in a solubility-improved form is combined with a concentration-enhancing polymer in a sufficient amount so that the combination provides substantially enhanced drug concentration in a use environment relative to a control comprising the same amount of the same solubility-improved form of drug without the concentration-enhancing polymer. | 12-26-2013 |
20140322325 | PHARMACEUTICAL COMPOSITIONS PROVIDING ENHANCED DRUG CONCENTRATIONS - A drug in a solubility-improved form is combined with a concentration-enhancing polymer in a sufficient amount so that the combination provides substantially enhanced drug concentration in a use environment relative to a control comprising the same amount of the same solubility-improved form of drug without the concentration-enhancing polymer. | 10-30-2014 |
20150024054 | SOLID PHARMACEUTICAL DISPERSIONS WITH ENHANCED BIOAVAILABILITY - Spray dried solid dispersions comprising a sparingly soluble drug and hydroxypropylmethylcellulose acetate succinate (HPMCAS) provide increased aqueous solubility and/or bioavailability in a use environment. | 01-22-2015 |
20150190518 | PHARMACEUTICAL COMPOSITIONS PROVIDING ENHANCED DRUG CONCENTRATIONS - A drug in a solubility-improved form is combined with a concentration-enhancing polymer in a sufficient amount so that the combination provides substantially enhanced drug concentration in a use environment relative to a control comprising the same amount of the same solubility-improved form of drug without the concentration-enhancing polymer. | 07-09-2015 |